The National Agency for Food and Drug Administration and Control (NAFDAC) has announced the recall of a specific batch of Deekins Amoxycillin 500mg capsules following reports of serious adverse drug reactions.
The affected batch, identified as lot number 4C639001, was manufactured by Eco-med Pharma Ltd and marketed by DevineKings Pharmaceutical Ltd.
In a statement shared on Wednesday via its official X (formerly Twitter) account, NAFDAC disclosed that the decision to recall the batch was prompted by reports from a hospital where three patients experienced severe reactions after being administered the capsules.
The agency highlighted the importance of public safety in the use of Amoxicillin, a penicillin-based antibiotic commonly prescribed for bacterial infections such as tonsillitis, bronchitis, pneumonia, and infections affecting the ear, nose, throat, skin, or urinary tract.
NAFDAC has urged healthcare professionals and the public to immediately discontinue the use of this batch and report any suspected cases of substandard or falsified medicines.
Reports can be made through the following channels:
- Phone: 0800-162-3322
- Email: sf.alert@nafdac.gov.ng
NAFDAC assures the public of its commitment to safeguarding health by addressing quality and safety concerns promptly.
